Securities code: Sirio Pharma Co.Ltd(300791) securities abbreviation: Sirio Pharma Co.Ltd(300791) announcement Code: 2022024 securities code: 123113 securities abbreviation: xianle convertible bonds
Notice on convening the 2021 annual general meeting of shareholders
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Sirio Pharma Co.Ltd(300791) Co., Ltd. (hereinafter referred to as “the company” and “the company”) is scheduled to hold the 2021 annual general meeting of shareholders on Thursday, May 5, 2022. The relevant matters of the meeting are hereby notified as follows: I. Basic information of the convening of the general meeting of shareholders
1. Session of the general meeting of shareholders: 2021 annual general meeting of shareholders.
2. Convener: the seventh meeting of the third board of directors of the company was held.
3. Legality and compliance of the meeting: the proposal on convening the 2021 annual general meeting of shareholders was reviewed and adopted at the 7th Meeting of the third board of directors of the company. The convening procedure shall comply with the provisions of relevant laws, administrative regulations, departmental rules, normative documents and the articles of association.
4. Date and time of the meeting:
(1) On site meeting time: 14:30 pm on Thursday, May 5, 2022;
(2) Online voting time: May 5, 2022
Among them, the specific time of online voting through the trading system of Shenzhen stock exchange is: 9:15-9:25, 9:30-11:30 and 13:00-15:00 on May 5, 2022;
The specific time of voting through the Internet voting system of Shenzhen stock exchange is any time during 9:15-15:00 on May 5, 2022.
5. Meeting method: the shareholders’ meeting adopts the combination of on-site voting and online voting.
(1) On site voting: shareholders attend the on-site meeting in person or entrust others to attend the on-site meeting through a power of attorney (see Annex II for details).
(2) Online voting: the company will provide an online voting platform to all shareholders through the trading system and Internet voting system of Shenzhen Stock Exchange. Shareholders can exercise their voting rights through the above system during online voting time.
6. Equity registration date: April 21, 2022 (Thursday)
7. Attendee
(1) As of the closing of Shenzhen Stock Exchange on the afternoon of April 21, 2022, all shareholders of the company registered in Shenzhen Branch of China Securities Depository and Clearing Co., Ltd. have the right to attend and vote at the shareholders’ meeting. Shareholders who are unable to attend the meeting in person for some reason can entrust an agent to attend the meeting and vote in writing, and the shareholder agent does not have to be a shareholder of the company.
(2) Directors, supervisors and senior managers of the company
(3) Lawyers and other relevant personnel employed by the company
8. Venue of the on-site meeting: conference room, administrative building, No. 83, Taishan Road, Longhu District, Shantou
2、 Matters considered at the meeting
remarks
proposal
Code of the ticked column of the proposal name
You can vote
100 total proposals: all proposals except cumulative voting proposals √
Non cumulative voting proposal
1.00 proposal on deliberation of 2021 annual report and summary √
2.00 proposal on reviewing the work report of the board of directors in 2021 √
3.00 proposal on reviewing the work report of the board of supervisors in 2021 √
4.00 proposal on deliberation of 2021 annual financial statement √
Proposal name remarks
5.00 proposal on the company’s 2021 profit distribution plan √
6.00 proposal on the company’s application for comprehensive bank credit in 2022 √
It is estimated that the company will provide a guarantee line for applying for bank credit to wholly-owned subsidiaries in 2022
7.00 proposal √
8.00 proposal on determining the amount of long-term foreign exchange settlement and sales of the company in 2022 √
9.00 proposal on using idle raised funds for cash management √
The above-mentioned proposal has been deliberated and adopted at the 7th Meeting of the 3rd board of directors and the 6th meeting of the 3rd board of supervisors of the company. For the content of the proposal, see the relevant announcement published on the information disclosure website designated by the CSRC.
The company will count the votes of small and medium-sized investors separately and disclose the voting results in accordance with relevant regulations. Small and medium-sized investors refer to other shareholders except directors, supervisors, senior managers and shareholders who individually or jointly hold more than 5% of the shares of the company.
3、 Meeting registration method
(I) registration time: Friday, April 22, 2022, 9:00-12:00 a.m. and 13:30-17:00 p.m.) (II) registration method: on-site registration, registration by letter or fax.
(III) registration procedures:
1. Registration of legal person shareholders: the legal representative of legal person shareholders must hold the shareholder account card, a copy of the business license stamped with the company’s official seal, the certificate of legal person representative and his own ID card to go through the registration procedures; If an agent is entrusted to attend, it shall also hold the power of attorney of the legal person and the ID card of the attendee.
2. Registration of natural person shareholders: natural person shareholders must go through the registration procedures with their own ID card and securities account card; If an agent is entrusted to attend, he must also hold the ID card of the attendee and the power of attorney.
(III) registration place and contact information: Office of Sirio Pharma Co.Ltd(300791) board of directors, No. 83, Taishan Road, Longhu District, Shantou City.
(IV) other matters: non local shareholders can register by letter or fax (the registration time shall be subject to the time of receiving the fax or letter). Please indicate the words “general meeting” on the letter and confirm by telephone after sending the fax. The company does not accept telephone registration.
4、 Specific operation process of participating in online voting
At this general meeting of shareholders, shareholders can vote through the trading system of Shenzhen Stock Exchange and the Internet voting system (website: http://wltp.cn.info.com.cn. ）See Annex III for the specific operation process of voting and online voting. 5、 Other
(I) the on-site meeting of the general meeting of shareholders lasts for half a day, and the accommodation and transportation expenses of the participants attending the on-site meeting shall be borne by themselves.
(II) contact information:
Tel.: 07548998 3800 (Office of the board of directors)
Contact location: Office of Sirio Pharma Co.Ltd(300791) board of directors, No. 83, Taishan Road, Longhu District, Shantou City.
Postal Code: 515041
Fax No.: 07548881 0300 (fax please indicate: received by the office of the board of directors)
(III) during online voting, if the online voting system is affected by major emergencies, the progress of the shareholders’ meeting shall be carried out according to the notice of the day.
6、 Documents for future reference
(I) resolutions of the seventh meeting of the third board of directors of the company;
(II) resolutions of the sixth meeting of the third board of supervisors of the company.
7、 Attachment
(I) registration form of shareholders attending the 2021 annual general meeting of shareholders;
(II) power of attorney of 2021 annual general meeting of shareholders;
(III) specific operation process of participating in online voting.
It is hereby notified.
Sirio Pharma Co.Ltd(300791) board of directors
April 14, 2002 Annex I:
Sirio Pharma Co.Ltd(300791)
Register of shareholders attending the 2021 annual general meeting
Name of natural person shareholder / name and address of legal person shareholder
Corporate shareholder
ID number / legal representative of natural person shareholder
Corporate shareholder unified social credit code executive partner
full name
Number of shareholder accounts
Is the name of the person attending the meeting entrusted
Agent name, agent ID number
Contact number e-mail
Speech intention and key points:
Signature of shareholder (seal of legal person shareholder)
specific date
note appended:
1. Please fill in your full name and address in block letters (which must be the same as that in the register of shareholders).
2. The completed and signed registration form of shareholders participating in the meeting should be delivered, mailed or faxed (Fax No.: 07548881 0300) to the company (address: Office of Sirio Pharma Co.Ltd(300791) board of directors, No. 83, Taishan Road, Longhu District, Shantou City, postal code: 515041, please indicate “general meeting” on the envelope) before 17:00 p.m. on Friday, April 22, 2022. Telephone registration is not accepted.
3. If a shareholder intends to speak at this shareholders’ meeting, please indicate your intention and key points in the “intention and key points of speech” column, and indicate the required time.
4. The newspaper clippings and copies of the above registration form of shareholders participating in the meeting or self-made in the above format are valid.
Annex II:
Sirio Pharma Co.Ltd(300791)
Power of attorney for 2021 annual general meeting
I hereby entrust myself (my company) to attend the Sirio Pharma Co.Ltd(300791) 2021 annual general meeting of shareholders on behalf of me (my company), and exercise the voting right on the proposals considered at the meeting according to the following opinions. If I (my company) have no specific instructions on the voting matters, the agent can exercise the voting right by himself / herself, and the consequences shall be borne by me (my company). This power of attorney is valid from the date of signing to the end of the meeting.
The instructions of the client to the trustee are as follows:
remarks
proposal
Code of the ticked column of the proposal name
You can vote
100 total proposals: all proposals except cumulative voting proposals √
Non cumulative voting proposal
1.00 proposal on deliberation of 2021 annual report and summary √
2.00 proposal on reviewing the work report of the board of directors in 2021 √
3.00 proposal on reviewing the work report of the board of supervisors in 2021 √
4.00 proposal on deliberation of 2021 annual financial statement √
5.00 proposal on the company’s 2021 profit distribution plan √
6.00 proposal on the company’s application for comprehensive bank credit in 2022
